Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Insight Molecular Diagnostics Inc IMDX

Healthcare Biotechnology
Insight Molecular Diagnostics Inc., formerly Oncocyte Corporation, is a molecular diagnostics technology company. The Company's technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is in the process of rebranding its VitaGraft assay (also known as VitaGraft Kidney), which is a lab developed test, under the name GraftAssureCore. The Company's transplant... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:IMDX)

iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing

GlobeNewswire June 23, 2025

Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

GlobeNewswire June 17, 2025

Medicare Boosts Reimbursement for Oncocyte's Flagship Technology

GlobeNewswire May 19, 2025

Oncocyte Reports Q1 2025 Results and Business Progress

GlobeNewswire May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

GlobeNewswire May 7, 2025

Oncocyte Provides Positive Update on Clinical Trial Progress

GlobeNewswire April 30, 2025

Oncocyte's Proprietary Assay Demonstrates Long-Term Clinical Validity

GlobeNewswire April 29, 2025

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2025

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

GlobeNewswire March 24, 2025
View More News ››

Opinion & Analysis (NDAQ:IMDX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:IMDX)

Oncocyte Corporation (NASDAQ:OCX): Transforming Diagnostics

http://beyondspx.com/2024/08/01/oncocyte-corporation-nasdaqocx-transforming-diagnostics-through-innovation-and-strategic-partnerships/
MikeTester - August 2, 2024

looking good!

looking good the last couple of days! :^)
robertwfb - May 17, 2019
View more Bullboard ››

Southern Energy Corp.

Southern Energy Corp.

Southern Energy Corp. is a Canada-based natural gas exploration and production company. The Company has a primary focus on ...
View More »